Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Sinclair grading effectively identifies female androgenic alopecia patterns, with Grade III most common.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

The conclusion is that the risk of losing significance in meta-analysis results increases with smaller effects and more missing data, and using the median standard deviation for imputation is recommended.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Taking biotin supplements can cause incorrect thyroid test results, leading to wrong diagnoses.

Female pattern baldness may indicate a higher risk of coronary artery disease.

Most patients experienced significant but reversible hair loss during treatment.

Data visualization tools are crucial for understanding and advancing androgenetic alopecia research.

Thicker scalp fat may link hair loss with metabolic syndrome.

PRP therapy with a derma roller is a safe and effective treatment for female hair loss.

Protein hair straighteners damage the hair more than hair dyes.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Using oral minoxidil and dutasteride together can quickly increase hair growth and volume with minimal side effects.

Androgenetic alopecia is more common in Indian men than women, and family history is a strong risk factor.

2.5 mg/day finasteride effectively treats female pattern hair loss.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Certain drugs that block specific enzymes can help treat prostate diseases.

South Korean women with hair loss have lower hair density and thickness compared to healthy women.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.